Browsing by Author "Yamancan, Gülşah"
Now showing items 1-2 of 2
-
The joint ınvolvement pattern of granulomatous polangiitis changed? Multicenter study
Albayrak, Fatih; Öz, Burak; Yamancan, Gülşah; Kutlu, Nagehan Dik; Kudaş, Özlem; Coşkun, Belkıs Nihan; Yağız, Burcu; Ermurat, Selime; Zengin, Orhan; Karataş, Ahmet; Koç, Emrah; Akyol, Lütfi; Balcı, Mehmet Ali; Zontul, Sezgin; Ağbuga, Özlem Doğan; Şen, Menice Güler; Yıldırım, Alper; Altuner, Mehmet Şakir; Cüre, Osman; Okyar, Burak; Çelik, Neşe Çabuk; Küçük, Adem; Tezcan, Dilek; Mengi, Alperen; Koca, Süleyman Serdar; Pehlivan, Yavuz; Kısacık, Bünyamin (Springer Nature, 2025)Objectives: Granulomatosis with polyangiitis (GPA) formerly Wegener’s granulomatosis is a type of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) typically associated with necrotizing, granulomatous ... -
Secukinumab may be an effective treatment option for axial spondyloarthritis and psoriatic arthritis patients with a history of malignancy: multicenter real-life experience from Turkey
Ocak, Tuğba; Yağız, Burcu; Ocak, Birol; Yoğurtçu, Özge; Başıbüyük, Fatma; Tezcan, Dilek; Ermurat, Selime; İnanç, Elif; Yamancan, Gülşah; Albayrak, Fatih; Sağır, Rabia Pişkin; Bayındır Akbaş, Ayşe Nur; Cüre, Osman; Coşkun, Belkıs Nihan; Yolbaş, Servet; Karasu, Uğur; Kısacık, Bünyamin; Koca, Süleyman Serdar; Sarı, İsmail; Akar, Servet; Pehlivan, Yavuz (MDPI, 2024)Background: Secukinumab is a monoclonal antibody against interleukin 17 approved for patients with axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), and psoriasis. Treating axSpA and PsA patients with a history ...
